An Aggregated-Based Deep Learning Method for Leukemic B-lymphoblast Classification.

Leukemia is a cancer of blood cells in the bone marrow that affects both children and adolescents. The rapid growth of unusual lymphocyte cells leads to bone marrow failure, which may slow down the production of new blood cells, and hence increases patient morbidity and mortality. Age is a crucial clinical factor in leukemia diagnosis, since if leukemia is diagnosed in the early stages, it is highly curable. Incidence is increasing globally, as around 412,000 people worldwide are likely to be diagnosed with some type of leukemia, of which acute lymphoblastic leukemia accounts for approximately 12% of all leukemia cases worldwide. Thus, the reliable and accurate detection of normal and malignant cells is of major interest. Automatic detection with computer-aided diagnosis (CAD) models can assist medics, and can be beneficial for the early detection of leukemia. In this paper, a single center study, we aimed to build an aggregated deep learning model for Leukemic B-lymphoblast classification. To make a reliable and accurate deep learner, data augmentation techniques were applied to tackle the limited dataset size, and a transfer learning strategy was employed to accelerate the learning process, and further improve the performance of the proposed network. The results show that our proposed approach was able to fuse features extracted from the best deep learning models, and outperformed individual networks with a test accuracy of 96.58% in Leukemic B-lymphoblast diagnosis.